Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,79.00,09/03/2014,GNRL,168528234
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,66.80,01/21/2015,GNRL,260123492
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.03,04/14/2015,GNRL,332296991
125415,GNRL,"Pfizer Inc.",NY,100000000286,63.28,09/07/2013,GNRL,205179788
125415,GNRL,"Pfizer Inc.",NY,100000000286,53.54,06/30/2014,GNRL,206792704
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,37.82,02/06/2014,GNRL,149813098
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,30.42,10/18/2015,GNRL,275866192
125415,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,30.42,10/17/2015,GNRL,337502654
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,28.27,06/19/2014,GNRL,187931748
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,25.74,04/11/2014,GNRL,187850372
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,25.00,12/09/2015,GNRL,319950066
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,24.89,04/02/2014,GNRL,168497354
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,24.05,12/04/2014,GNRL,188173604
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.45,01/24/2014,GNRL,187742400
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,23.39,10/24/2013,GNRL,14011982
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,22.94,10/02/2013,GNRL,101657302
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.68,02/06/2014,GNRL,149853218
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.44,06/11/2014,GNRL,196485438
125415,GNRL,"Stryker Corporation",MI,100000010503,21.22,09/16/2013,GNRL,104162524
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.15,06/25/2014,GNRL,148731524
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.86,02/18/2015,GNRL,290589700
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,20.67,10/27/2014,GNRL,156931126
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.25,09/25/2013,GNRL,32249278
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,20.10,11/02/2015,GNRL,332489499
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.93,09/30/2014,GNRL,168547910
125415,GNRL,"Pfizer Inc.",NY,100000000286,19.92,04/01/2014,GNRL,206900894
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.80,11/20/2013,GNRL,12272915
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.76,05/28/2015,GNRL,331663349
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.47,07/27/2015,GNRL,331796834
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.27,09/18/2015,GNRL,331956138
125415,GNRL,"Pfizer Inc.",NY,100000000286,19.26,03/07/2014,GNRL,206335872
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.20,04/29/2015,GNRL,290589698
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.14,11/07/2013,GNRL,13989932
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.07,01/08/2015,GNRL,260114424
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.01,12/30/2015,GNRL,275866172
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,18.95,06/03/2015,GNRL,269776474
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.92,03/19/2015,GNRL,331569327
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.85,06/18/2014,GNRL,196485436
125415,GNRL,"LILLY USA, LLC",IN,100000000066,18.67,12/09/2013,GNRL,4739785
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.46,04/17/2014,GNRL,148294412
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,18.42,09/03/2014,GNRL,188050842
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.40,09/23/2013,GNRL,104437530
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.35,08/16/2013,GNRL,103340212
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.34,04/21/2014,GNRL,149799868
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.28,04/10/2015,GNRL,337078606
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.21,09/22/2014,GNRL,196485426
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.71,12/12/2014,GNRL,188182438
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.68,12/21/2015,GNRL,290589684
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.62,03/01/2015,GNRL,270257770
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.53,02/03/2014,GNRL,196485284
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.49,10/12/2015,GNRL,332049716
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.41,10/07/2015,GNRL,319950068
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.33,10/06/2014,GNRL,198738346
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.17,03/17/2014,GNRL,198648132
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.02,10/15/2015,GNRL,260093084
125415,GNRL,"AbbVie, Inc.",IL,100000000204,16.94,09/06/2013,GNRL,104616416
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.94,12/03/2014,GNRL,188171140
125415,GNRL,"AbbVie, Inc.",IL,100000000204,16.94,04/30/2014,GNRL,189297420
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.90,01/09/2015,GNRL,331487799
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.70,12/03/2015,GNRL,275866190
125415,GNRL,"AbbVie, Inc.",IL,100000000204,16.67,03/05/2014,GNRL,189199668
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.59,09/23/2015,GNRL,290589688
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.48,05/11/2015,GNRL,294758580
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.44,10/28/2014,GNRL,188125444
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.39,07/30/2014,GNRL,161752560
125415,GNRL,"Lilly USA, LLC",IN,100000000066,16.32,05/29/2015,GNRL,268195742
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.28,10/14/2015,GNRL,275866170
125415,GNRL,"Lilly USA, LLC",IN,100000000066,16.20,06/10/2015,GNRL,268195738
125415,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.14,06/27/2014,GNRL,199577610
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.02,07/08/2015,GNRL,319950050
125415,GNRL,"AbbVie, Inc.",IL,100000000204,16.01,11/14/2014,GNRL,189602064
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.93,01/20/2015,GNRL,336833330
125415,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,15.91,10/28/2013,GNRL,105082468
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.90,04/01/2015,GNRL,260123014
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.88,06/26/2014,GNRL,161530138
125415,GNRL,"Pfizer Inc.",NY,100000000286,15.78,10/31/2014,GNRL,206775178
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.58,11/25/2015,GNRL,270246696
125415,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,15.39,11/11/2013,GNRL,24097208
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.34,05/19/2014,GNRL,161370286
125415,GNRL,"AbbVie, Inc.",IL,100000000204,15.30,03/12/2015,GNRL,309145858
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.30,08/26/2015,GNRL,319950058
125415,GNRL,"AbbVie, Inc.",IL,100000000204,15.28,09/17/2014,GNRL,189504454
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.20,08/21/2014,GNRL,198708168
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.19,07/09/2014,GNRL,156931142
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.03,05/20/2015,GNRL,319950042
125415,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.94,12/11/2015,GNRL,339491192
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.92,07/02/2014,GNRL,148709846
125415,GNRL,"Lilly USA, LLC",IN,100000000066,14.84,07/10/2015,GNRL,268195740
125415,GNRL,"AbbVie, Inc.",IL,100000000204,14.84,09/16/2015,GNRL,317134468
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.81,08/28/2014,GNRL,161982718
125415,GNRL,"Pfizer Inc.",NY,100000000286,14.78,12/23/2013,GNRL,205922298
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.78,09/30/2015,GNRL,260116740
125415,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,14.74,07/16/2015,GNRL,283337932
125415,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.68,05/18/2015,GNRL,339479518
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.66,08/27/2014,GNRL,196485428
125415,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.65,07/24/2015,GNRL,339477372
125415,GNRL,"LILLY USA, LLC",IN,100000000066,14.63,04/25/2014,GNRL,137571710
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.57,05/09/2014,GNRL,161233120
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.46,11/07/2014,GNRL,196485422
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.36,12/12/2014,GNRL,150933676
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.36,01/29/2015,GNRL,319010487
125415,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.33,10/08/2013,GNRL,108652860
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.22,01/19/2015,GNRL,275866164
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.18,03/04/2015,GNRL,275866166
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.17,03/28/2014,GNRL,156931120
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.05,06/24/2015,GNRL,337240444
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.97,10/29/2014,GNRL,198739786
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.94,02/04/2014,GNRL,198633100
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.90,10/15/2014,GNRL,162311676
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.87,08/06/2015,GNRL,319444882
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.82,09/12/2014,GNRL,168422726
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.77,02/12/2014,GNRL,160690242
125415,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.68,12/09/2013,GNRL,24097207
125415,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.60,04/09/2015,GNRL,333452464
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.58,04/24/2014,GNRL,188539302
125415,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.54,06/17/2014,GNRL,199577606
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.53,03/20/2014,GNRL,149019690
125415,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.50,12/03/2015,GNRL,263312468
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.49,12/12/2013,GNRL,23817899
125415,GNRL,"SANOFI PASTEUR INC.",PA,100000000299,13.45,03/18/2015,GNRL,318740724
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.41,07/06/2015,GNRL,290589694
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.27,10/26/2015,GNRL,290589686
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.23,05/07/2014,GNRL,196485440
125415,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.20,12/15/2014,GNRL,216279548
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.18,09/27/2013,GNRL,23817894
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.18,12/04/2015,GNRL,260088832
125415,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.17,10/16/2013,GNRL,171867650
125415,GNRL,"Pfizer Inc.",NY,100000000286,13.16,09/16/2014,GNRL,205951598
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.13,08/26/2013,GNRL,12108171
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.10,09/04/2013,GNRL,12265471
125415,GNRL,"Pfizer Inc.",NY,100000000286,12.83,08/21/2015,GNRL,323438486
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.81,01/30/2015,GNRL,332345815
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.74,01/02/2015,GNRL,269546524
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.72,10/03/2013,GNRL,23817896
125415,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.71,09/09/2015,GNRL,283337934
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.60,01/28/2015,GNRL,319950032
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.56,12/01/2014,GNRL,168729566
125415,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,12.49,08/07/2014,GNRL,163250888
125415,GNRL,"LILLY USA, LLC",IN,100000000066,12.47,10/10/2014,GNRL,137924030
125415,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.47,08/18/2015,GNRL,339349312
125415,GNRL,"Amgen Inc.",CA,100000000203,12.46,09/22/2015,GNRL,297882786
125415,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,12.43,09/10/2015,GNRL,263312466
125415,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,12.42,03/03/2014,GNRL,216279546
125415,GNRL,"Lilly USA, LLC",IN,100000000066,12.34,10/23/2015,GNRL,268195744
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.30,11/21/2013,GNRL,104361412
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.25,07/03/2014,GNRL,168478782
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.19,06/18/2015,GNRL,318999812
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.15,09/17/2015,GNRL,260066538
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.05,05/02/2014,GNRL,161220172
125415,GNRL,"Shire North American Group Inc",MA,100000061292,12.02,10/30/2015,GNRL,301086954
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.01,11/03/2014,GNRL,194792064
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.97,12/09/2013,GNRL,13989933
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.95,10/28/2015,GNRL,270034826
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.90,08/27/2015,GNRL,269955556
125415,GNRL,"Pfizer Inc.",NY,100000000286,11.84,03/06/2015,GNRL,322992592
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.77,07/22/2014,GNRL,198695012
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.77,06/25/2015,GNRL,260110676
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.74,12/04/2014,GNRL,148695098
125415,GNRL,"Shire North American Group Inc",MA,100000061292,11.70,05/21/2015,GNRL,300296828
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.68,01/30/2015,GNRL,269647340
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.67,07/20/2015,GNRL,294907060
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,11/04/2013,GNRL,23817897
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.66,10/21/2014,GNRL,156931138
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.63,12/18/2014,GNRL,162347730
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.59,09/20/2013,GNRL,103340214
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.57,05/22/2015,GNRL,319026100
125415,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,11.46,11/17/2014,GNRL,163285538
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.44,11/24/2014,GNRL,198750902
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.37,08/23/2015,GNRL,275866184
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.34,07/09/2015,GNRL,260093376
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.31,10/25/2013,GNRL,13982412
125415,GNRL,"LILLY USA, LLC",IN,100000000066,11.24,05/16/2014,GNRL,137595998
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.19,07/24/2014,GNRL,196485434
125415,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.16,02/05/2014,GNRL,199577600
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.12,07/31/2014,GNRL,196485432
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.09,02/13/2014,GNRL,196485282
125415,GNRL,"Sanofi Pasteur Inc.",PA,100000000299,11.07,03/12/2014,GNRL,182341906
125415,GNRL,"Shire US Holdings",PA,100000000241,11.03,10/17/2013,GNRL,6371407
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.01,04/09/2015,GNRL,337073470
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.98,10/13/2015,GNRL,295070656
125415,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.94,08/07/2013,GNRL,108635022
125415,GNRL,"Amgen Inc.",CA,100000000203,10.85,07/16/2014,GNRL,138220546
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.83,09/11/2015,GNRL,290589690
125415,GNRL,"Lilly USA, LLC",IN,100000000066,10.78,01/12/2015,GNRL,268195736
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.75,12/30/2014,GNRL,207346646
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.74,12/30/2013,GNRL,104329546
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.73,10/04/2013,GNRL,205040026
125415,GNRL,"Amgen Inc.",CA,100000000203,10.71,11/04/2015,GNRL,297882784
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.70,02/04/2015,GNRL,260039023
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.70,09/04/2015,GNRL,337328238
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.61,10/14/2014,GNRL,207079100
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.60,11/04/2014,GNRL,196485424
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.56,08/20/2015,GNRL,275866174
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.55,09/19/2013,GNRL,14011983
125415,GNRL,"Shionogi Inc",NJ,100000005589,10.52,01/10/2014,GNRL,217449002
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.52,01/23/2015,GNRL,290589702
125415,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,10.50,03/05/2015,GNRL,283337930
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.50,12/07/2015,GNRL,332218159
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.49,02/14/2014,GNRL,206463662
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.49,07/19/2014,GNRL,198692266
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.42,07/27/2014,GNRL,148339214
125415,GNRL,"Amgen Inc.",CA,100000000203,10.42,03/02/2015,GNRL,297882782
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.41,11/20/2015,GNRL,332218121
125415,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,10.39,03/27/2014,GNRL,163239278
125415,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.37,01/22/2014,GNRL,152433696
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.28,12/08/2014,GNRL,196485420
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.28,01/15/2015,GNRL,322927632
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.25,10/31/2013,GNRL,14011984
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.21,04/04/2014,GNRL,196485442
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.20,08/05/2015,GNRL,269920501
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.19,02/28/2014,GNRL,206658234
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.11,08/10/2015,GNRL,290589692
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.10,04/11/2014,GNRL,194792058
125415,GNRL,"Pfizer Inc.",NY,100000000286,10.01,06/05/2014,GNRL,206414266
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.00,09/30/2015,GNRL,275866178
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.96,11/09/2015,GNRL,290140474
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.96,05/15/2015,GNRL,323846160
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.91,12/03/2013,GNRL,103340210
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,9.64,08/09/2013,GNRL,14042879
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.60,04/30/2015,GNRL,290589696
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.59,08/13/2015,GNRL,323931214
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.53,05/21/2014,GNRL,194792067
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.53,05/01/2015,GNRL,269683632
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.40,08/08/2014,GNRL,205746322
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.40,01/22/2015,GNRL,319950020
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.26,08/15/2014,GNRL,196485430
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.16,04/07/2015,GNRL,322461448
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.08,04/22/2015,GNRL,319950038
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.05,03/13/2014,GNRL,206921874
125415,GNRL,"Pfizer Inc.",NY,100000000286,9.04,05/07/2015,GNRL,322446146
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.96,06/02/2014,GNRL,156931132
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.95,12/18/2015,GNRL,323712448
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.92,08/22/2014,GNRL,161836374
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.82,10/09/2013,GNRL,205516398
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,8.82,01/09/2014,GNRL,187707946
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.75,06/06/2014,GNRL,161474474
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.75,03/06/2014,GNRL,206866670
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.67,04/02/2015,GNRL,319646943
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.66,03/25/2015,GNRL,323299802
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.61,11/05/2013,GNRL,205715638
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.56,02/05/2015,GNRL,323946204
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.53,06/12/2015,GNRL,319780730
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.48,07/28/2014,GNRL,156931134
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.42,07/01/2014,GNRL,161702684
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.40,03/27/2015,GNRL,318573164
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.38,08/06/2015,GNRL,323471050
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.34,02/13/2015,GNRL,323090646
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.32,08/02/2013,GNRL,205643394
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.24,06/13/2014,GNRL,206887612
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.23,10/03/2014,GNRL,162176836
125415,GNRL,"Pfizer Inc.",NY,100000000286,8.23,01/03/2014,GNRL,206595646
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.02,04/07/2014,GNRL,156931128
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,8.01,06/01/2015,GNRL,319950046
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.00,05/29/2014,GNRL,156931124
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.00,06/11/2015,GNRL,337250800
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.95,02/26/2014,GNRL,196485280
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.94,02/06/2015,GNRL,270259132
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.91,11/05/2015,GNRL,270099810
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.85,11/13/2013,GNRL,205882560
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.82,09/03/2015,GNRL,322984772
125415,GNRL,"LILLY USA, LLC",IN,100000000066,7.58,12/13/2013,GNRL,4730070
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.58,07/29/2015,GNRL,323928416
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.52,06/26/2015,GNRL,269867614
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.52,07/13/2015,GNRL,337276052
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.48,12/20/2013,GNRL,205642039
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.46,08/04/2014,GNRL,194792070
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.45,07/23/2014,GNRL,206255314
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.42,09/19/2014,GNRL,205664154
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.34,02/02/2015,GNRL,336874046
125415,GNRL,"Pfizer Inc.",NY,100000000286,7.13,05/08/2014,GNRL,206832568
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.98,02/25/2015,GNRL,318514570
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.91,11/23/2015,GNRL,323895230
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,6.91,03/09/2015,GNRL,319950036
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.89,09/11/2014,GNRL,206753560
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.74,08/12/2013,GNRL,205864474
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.74,02/27/2014,GNRL,206448966
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.73,03/13/2015,GNRL,319574024
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.61,09/12/2014,GNRL,206368056
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.59,04/24/2014,GNRL,205593630
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.47,06/30/2015,GNRL,318835984
125415,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.25,07/21/2015,GNRL,318546605
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.17,11/17/2015,GNRL,275866186
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.15,05/22/2014,GNRL,207361476
125415,GNRL,"Pfizer Inc.",NY,100000000286,6.13,10/21/2015,GNRL,323882714
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.87,08/14/2013,GNRL,205419718
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/26/2014,GNRL,205699070
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.86,11/18/2015,GNRL,322683504
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.68,02/10/2015,GNRL,323983624
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.62,01/15/2014,GNRL,206793358
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,5.59,01/30/2014,GNRL,196485286
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,5.58,05/11/2015,GNRL,269720104
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,5.43,11/19/2015,GNRL,319950062
125415,GNRL,"Pfizer Inc.",NY,100000000286,5.02,10/18/2013,GNRL,205221012
125415,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,4.88,06/12/2014,GNRL,163229602
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.75,04/02/2015,GNRL,269661738
125415,GNRL,"Pfizer Inc.",NY,100000000286,3.99,08/24/2015,GNRL,323313072
125415,GNRL,"Pfizer Inc.",NY,100000000286,3.90,05/20/2015,GNRL,323027082
125415,GNRL,"Pfizer Inc.",NY,100000000286,3.82,04/23/2015,GNRL,323223152
125415,GNRL,"Pfizer Inc.",NY,100000000286,3.82,08/12/2015,GNRL,323885816
125415,GNRL,"Pfizer Inc.",NY,100000000286,3.25,05/18/2015,GNRL,322814772
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.95,07/28/2014,GNRL,156931144
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.59,09/15/2015,GNRL,323814284
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.53,08/17/2015,GNRL,323137012
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.46,06/20/2014,GNRL,206606382
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.40,01/30/2015,GNRL,269570354
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.27,12/31/2015,GNRL,323913474
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.14,10/12/2015,GNRL,323574540
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.14,05/12/2015,GNRL,323409292
125415,GNRL,"Pfizer Inc.",NY,100000000286,2.13,09/25/2015,GNRL,323020712
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.95,11/07/2013,GNRL,13989930
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.70,07/03/2014,GNRL,168826236
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.66,09/16/2014,GNRL,156931136
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.64,10/21/2015,GNRL,323992670
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.61,07/31/2014,GNRL,205961835
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.61,11/05/2015,GNRL,270099764
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.55,02/13/2014,GNRL,206613374
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.53,10/25/2013,GNRL,13982413
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.51,12/05/2013,GNRL,205172916
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.50,12/09/2015,GNRL,323401586
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.48,01/15/2014,GNRL,206499708
125415,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,12/21/2015,GNRL,290589682
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.47,02/13/2015,GNRL,323828492
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.46,12/04/2015,GNRL,322917972
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.42,10/01/2015,GNRL,275866180
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.39,05/02/2014,GNRL,161220160
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.36,12/03/2015,GNRL,275866188
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.35,01/02/2015,GNRL,269572814
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.34,04/23/2014,GNRL,205563234
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.29,09/30/2014,GNRL,168640042
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.28,11/26/2014,GNRL,206809236
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.21,03/24/2015,GNRL,322318542
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.18,10/09/2013,GNRL,205059708
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.17,08/14/2013,GNRL,205033126
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.17,03/02/2015,GNRL,323639932
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.13,04/07/2015,GNRL,323753880
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.10,05/01/2015,GNRL,269683654
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.08,09/12/2014,GNRL,206905784
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.08,10/09/2014,GNRL,206647074
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.06,12/20/2013,GNRL,206083354
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.04,03/04/2015,GNRL,275866168
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.03,08/17/2015,GNRL,323137026
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/06/2015,GNRL,322851286
125415,GNRL,"Pfizer Inc.",NY,100000000286,1.00,10/29/2015,GNRL,322853348
125415,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.97,07/03/2014,GNRL,168917680
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.95,06/09/2015,GNRL,322896560
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.93,03/13/2014,GNRL,207181740
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.90,11/20/2013,GNRL,205351106
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.90,10/14/2014,GNRL,206880798
125415,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.89,04/10/2014,GNRL,194792052
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.89,05/08/2015,GNRL,323518388
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.88,08/07/2015,GNRL,322707866
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.87,06/26/2015,GNRL,269867628
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.87,11/23/2015,GNRL,323845812
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.86,08/20/2015,GNRL,275866176
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.83,08/22/2014,GNRL,161836388
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.82,12/18/2015,GNRL,323949112
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.79,12/09/2013,GNRL,13989931
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.78,05/22/2014,GNRL,206380940
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.77,11/23/2015,GNRL,322908947
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.76,05/02/2014,GNRL,161220140
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.76,08/26/2015,GNRL,319950054
125415,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.75,08/09/2013,GNRL,14042880
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.74,09/24/2014,GNRL,206285820
125415,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,0.73,08/07/2014,GNRL,163268456
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.72,01/02/2015,GNRL,269546528
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.71,07/01/2014,GNRL,161702676
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.71,05/19/2014,GNRL,161370290
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.71,09/24/2014,GNRL,206199170
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.70,06/06/2014,GNRL,161474510
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.68,02/27/2014,GNRL,206973056
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.61,08/05/2015,GNRL,269919802
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.60,11/05/2013,GNRL,206090686
125415,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,0.60,06/25/2014,GNRL,148811124
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.60,02/10/2015,GNRL,323931764
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.58,08/23/2015,GNRL,275866182
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.57,11/20/2013,GNRL,205905830
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.56,06/05/2014,GNRL,207172322
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.54,08/02/2013,GNRL,205154090
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.54,01/30/2015,GNRL,269570254
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.53,07/09/2014,GNRL,156931140
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.53,12/30/2014,GNRL,206476392
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.52,10/06/2014,GNRL,198738348
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.49,08/12/2013,GNRL,205305170
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.49,12/23/2013,GNRL,205242977
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.49,03/28/2014,GNRL,156931130
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.49,01/03/2014,GNRL,207198142
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.47,08/17/2015,GNRL,322785726
125415,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.46,05/29/2014,GNRL,156931122
125415,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.45,05/10/2014,GNRL,161233142
125415,GNRL,"LILLY USA, LLC",IN,100000000066,0.44,12/13/2013,GNRL,4738761
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.42,02/24/2015,GNRL,323153268
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.42,01/13/2015,GNRL,323625540
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.42,01/22/2015,GNRL,319950024
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.41,10/04/2013,GNRL,205695448
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.35,08/17/2015,GNRL,322932840
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.32,02/10/2015,GNRL,323189290
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.29,07/22/2014,GNRL,198695008
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.27,07/29/2015,GNRL,322703564
125415,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.22,01/28/2015,GNRL,319950028
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.20,10/18/2013,GNRL,205724274
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.18,08/08/2014,GNRL,206832502
125415,GNRL,"Pfizer Inc.",NY,100000000286,0.18,10/21/2015,GNRL,323502739
